These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13673366)

  • 21. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.
    Scannell RT; Arrington MP; Bayless L; Cai X; Eckman JB; Eckert M; Ene DG; Ellis JL; Hussoin S; Latham GM; Lewis TA; Libertine L; Nicolas J; Selig WM; Schwartz CE; Wels BF; Wypij DM; Young MA; Zou D
    Inflamm Res; 2004 Mar; 53 Suppl 1():S33-4. PubMed ID: 15054606
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinico-metabolic actoin of some phenylbutazone derivatives (G 27202, G 28315 and keto-phenylbutazone)].
    CIRLA E; RATTI G
    Reumatismo; 1960; 12():76-80. PubMed ID: 13693726
    [No Abstract]   [Full Text] [Related]  

  • 24. The uricosuric effect of certain oral anticoagulant drugs.
    THOMPSON GR; MIKKELSEN WM; WILLIS PW
    Arthritis Rheum; 1959 Oct; 2():383-8. PubMed ID: 13838062
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists.
    Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Vilella D; Aparici M; Prieto J; Warrellow G; Beleta J; Ryder H
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1165-7. PubMed ID: 15686934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological properties of 1,2-diphenyl-4-(gamma-ketobutyl)-pyrazolidine-3,5-dione].
    HORAKOVA Z; NEMECEK O; PUJMAN V; MAYER J; CTVRTNIK J; VOTAVA Z
    Arzneimittelforschung; 1958 Apr; 8(4):229-31. PubMed ID: 13535357
    [No Abstract]   [Full Text] [Related]  

  • 27. Phenylbutazone and its derivatives with special reference to G.27202.
    HART FD; BURLEY D
    Br Med J; 1959 Apr; 1(5129):1087-9. PubMed ID: 13638638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative toxicity of various phenylbutazone derivatives].
    DEROUAUX G; OLEFFE-KOOPMANSCH S
    C R Seances Soc Biol Fil; 1961; 155():1419-20. PubMed ID: 13885610
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent uric acid stones.
    Kamel KS; Cheema-Dhadli S; Shafiee MA; Davids MR; Halperin ML
    QJM; 2005 Jan; 98(1):57-68. PubMed ID: 15625355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemiluminescence microflow injection analysis system on a chip for the determination of uric acid without enzyme.
    He D; Zhang Z; Huang Y; Hu Y; Zhou H; Chen D
    Luminescence; 2005; 20(4-5):271-5. PubMed ID: 16134228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical test of the antiphlogistic properties of Tanderil following phimosis operations].
    DITTRICH H; SCHARF H
    Med Welt; 1961 Aug; 34():1710-1. PubMed ID: 13723111
    [No Abstract]   [Full Text] [Related]  

  • 32. The validity of fractional excretion of uric acid in the diagnosis of acute kidney injury due to decreased kidney perfusion.
    Kosmadakis G; Viskaduraki M; Michail S
    Am J Kidney Dis; 2009 Dec; 54(6):1186-7. PubMed ID: 19932879
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of phenylbutazone on uric acid in plasma and erythrocytes; relation to clinical phenomena].
    LEVY M; SICHERE RM
    Rev Rhum Mal Osteoartic; 1955 Mar; 22(3):225-33. PubMed ID: 14396123
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of some phenylbutazone derivatives on various edematous reactions in the rat].
    FRANCHIMONT P; LECOMTE J; van CAUWENBERGE H
    C R Seances Soc Biol Fil; 1960; 154():2383-6. PubMed ID: 13701213
    [No Abstract]   [Full Text] [Related]  

  • 35. [New esters of phenylbutazone].
    Santoro MI; Ferreira PC
    Boll Chim Farm; 1975 Oct; 114(10):558-68. PubMed ID: 1220713
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of sulfinpyrazone (Anturane) and other thio analogues of phenylbutazone in man.
    DAYTON PG; SICAM LE; LANDRAU M; BURNS JJ
    J Pharmacol Exp Ther; 1961 Jun; 132():287-90. PubMed ID: 13720360
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic properties of tropine 4-chlorobenzhydryl ether hydrochloride (SL-6057), a potent long-acting antihistaminic agent.
    CHEN JY
    J Pharmacol Exp Ther; 1955 Jun; 114(2):192-202. PubMed ID: 14392587
    [No Abstract]   [Full Text] [Related]  

  • 38. A study on the use of phenylbutazone and oxyphenbutazone in obstetrics and gynecology.
    RADMAN HM
    Sinai Hosp J (Balt); 1960; 9():225-30. PubMed ID: 13738978
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new treatment of traumatic conditions, by metabolite I of phenylbutazone, or G-27202. Preliminary note].
    WETTREICH W
    Hospital (Rio J); 1961 Dec; 60():895-902. PubMed ID: 14006389
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term treatment with the anti-rheumatic drug G27202.
    O'REILLY TJ
    J Ir Med Assoc; 1960 Apr; 46():106-7. PubMed ID: 14428119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.